{"id":149799,"date":"2025-03-01T11:26:19","date_gmt":"2025-03-01T08:26:19","guid":{"rendered":"https:\/\/coinmuhendisi.com\/blog\/?p=149799"},"modified":"2025-03-01T11:26:19","modified_gmt":"2025-03-01T08:26:19","slug":"vitadao-vita-nedir","status":"publish","type":"post","link":"https:\/\/coinmuhendisi.com\/blog\/vitadao-vita-nedir\/","title":{"rendered":"VitaDAO (VITA) Nedir?"},"content":{"rendered":"

Bilimsel ara\u015ft\u0131rma ve ila\u00e7 geli\u015ftirmenin \u00f6n\u00fcndeki en b\u00fcy\u00fck engellerden biri, erken a\u015fama ara\u015ft\u0131rmalar\u0131n fon bulamamas\u0131d\u0131r. VitaDAO<\/strong>, blockchain<\/strong> ve tokenizasyon<\/strong> teknolojilerini kullanarak bu s\u00fcreci merkeziyetsiz hale getirir ve topluluk destekli fonlama sa\u011flar. Molecule<\/strong>\u2019\u00fcn IP-NFT<\/strong> ve IPT<\/strong> sistemleriyle bilim insanlar\u0131na yeni bir finansman modeli sunar.<\/p>\n

Merkeziyetsiz Bilim (DeSci) Nedir?<\/h2>\n

DeSci<\/strong>, bilimsel ara\u015ft\u0131rmalar\u0131n finansman\u0131n\u0131 ve y\u00f6netimini toplulu\u011fa a\u00e7an, sans\u00fcre dayan\u0131kl\u0131 bir yap\u0131 sunar. Geleneksel hibeler ve risk sermayelerine ba\u011fl\u0131 kalmadan, bilim insanlar\u0131 blockchain<\/strong> \u00fczerinden fon toplayabilir, \u00e7al\u0131\u015fmalar\u0131n\u0131 belgeleyebilir ve IP\u2019lerini y\u00f6netebilirler.<\/p>\n

VitaDAO Nas\u0131l \u00c7al\u0131\u015f\u0131yor?<\/h2>\n

VitaDAO<\/strong>, erken a\u015fama uzun \u00f6m\u00fcrl\u00fcl\u00fck ara\u015ft\u0131rmalar\u0131n\u0131 destekleyen bir topluluk DAO\u2019sudur. \u00dcyeleri aras\u0131nda akademik bilim insanlar\u0131, ila\u00e7 \u015firketleri (Pfizer<\/strong> gibi) ve kripto d\u00fcnyas\u0131ndan \u00f6nemli isimler (Balaji Srinivasan<\/strong>) bulunur. VITA<\/strong> token sahipleri, projelerin finansman\u0131 ve y\u00f6netimi konusunda oy kullanabilir.<\/p>\n

Molecule<\/strong> platformu sayesinde ara\u015ft\u0131rmac\u0131lar, \u00e7al\u0131\u015fmalar\u0131n\u0131 NFT<\/strong> format\u0131nda (IP-NFT<\/strong>) blockchain\u2019e kaydedebilir. Bu IP\u2019ler IPT<\/strong> olarak tokenle\u015ftirilebilir ve yat\u0131r\u0131mc\u0131lara sat\u0131labilir.<\/p>\n

\"\"<\/p>\n

IP-NFT ve IPT\u2019ler ile Bilimsel Fonlama<\/h2>\n
    \n
  • IP-NFT\u2019ler<\/strong>, bilimsel ara\u015ft\u0131rmalar\u0131n blockchain<\/strong> \u00fczerinde tokenle\u015ftirilmesini sa\u011flar. Ara\u015ft\u0131rmac\u0131lar, IP-NFT<\/strong> satarak fon bulabilir.<\/li>\n
  • IPT\u2019ler<\/strong> ise IP-NFT\u2019ler<\/strong>\u2019in daha k\u00fc\u00e7\u00fck tokenlere b\u00f6l\u00fcnm\u00fc\u015f versiyonlar\u0131d\u0131r. Sahipleri, proje y\u00f6netimine kat\u0131labilir.<\/li>\n
  • VitaDAO\u2019nun ilk IPT projesi olan VITA-FAST<\/strong>, h\u00fccresel gen\u00e7le\u015firme \u00fczerine \u00e7al\u0131\u015fmalara fon sa\u011flamaktad\u0131r.<\/li>\n<\/ul>\n

    \"\"<\/p>\n

    VitaDAO\u2019nun BioPharma Alan\u0131ndaki Rol\u00fc<\/h2>\n
      \n
    • Daha iyi i\u015f birli\u011fi ve likidite:<\/strong> Bilim insanlar\u0131, NFT<\/strong>\u2019ler sayesinde IP sahipli\u011fini do\u011frulayabilir ve di\u011fer laboratuvarlarla \u00e7al\u0131\u015fmalar\u0131n\u0131 payla\u015fabilir.<\/li>\n
    • Daha kaliteli ve uygun maliyetli ila\u00e7 geli\u015ftirme:<\/strong> IPT\u2019ler<\/strong>, hasta ve ara\u015ft\u0131rmac\u0131lara daha fazla y\u00f6netim hakk\u0131 vererek \u00e7al\u0131\u015fmalar\u0131n verimlili\u011fini art\u0131r\u0131r.<\/li>\n
    • Proje ke\u015ffedilebilirli\u011fini art\u0131rma:<\/strong> Molecule<\/strong> ortakl\u0131\u011f\u0131yla, ara\u015ft\u0131rmac\u0131lar projelerini daha geni\u015f bir yat\u0131r\u0131mc\u0131 kitlesine sunabilir.<\/li>\n<\/ul>\n
      \n

      \u0130lginizi \u00c7ekebilir: Libra Coin Skandal\u0131 Sonras\u0131 Arjantin Borsas\u0131 \u00c7ak\u0131ld\u0131!<\/a><\/em><\/strong><\/p>\n

      \n

      VitaDAO Ekibi<\/h2>\n

      VitaDAO<\/strong>, uzun \u00f6m\u00fcr ve biyoteknoloji alan\u0131nda uzmanla\u015fm\u0131\u015f yetenekli bir ekip taraf\u0131ndan y\u00f6netilmektedir. Farkl\u0131 alanlardaki uzmanl\u0131klar\u0131 sayesinde DeSci<\/strong> ekosistemine katk\u0131da bulunarak bilimsel inovasyonu desteklemektedirler.<\/p>\n

        \n
      • Tim Peterson<\/strong> \u2013 Dealflow Steward<\/strong>
        Cambridge, Massachusetts merkezli olan Peterson, Harvard \u00dcniversitesi<\/strong> mezunudur. Daha \u00f6nce Leangap\u2019te CTO ve kurucu ortak<\/strong> olarak g\u00f6rev alm\u0131\u015ft\u0131r.<\/li>\n
      • Laurence Ion<\/strong> \u2013 Dealflow Steward<\/strong>
        Texas, Earth b\u00f6lgesinde yer alan Ion, ge\u00e7mi\u015fte Intersect\u2019in kurucusu<\/strong> ve Wabbit\u2019in CEO ve kurucu orta\u011f\u0131<\/strong> olarak \u00e7al\u0131\u015fm\u0131\u015ft\u0131r.<\/li>\n
      • Alex Dobrin<\/strong> \u2013 Awareness Steward<\/strong>
        B\u00fckre\u015f, Romanya\u2019da bulunan Dobrin, B\u00fckre\u015f \u00dcniversitesi\u2019nden mezun olmu\u015ftur<\/strong>. Daha \u00f6nce Wabbit\u2019te CPO ve geli\u015ftirici<\/strong> olarak g\u00f6rev yapm\u0131\u015ft\u0131r.<\/li>\n
      • Sebastian Brunemeier<\/strong> \u2013 Longevity Working Group<\/strong>
        Oxford, \u0130ngiltere\u2019de bulunan Brunemeier, Vrije Universiteit Amsterdam\u2019da Life Science Business Management e\u011fitimi alm\u0131\u015ft\u0131r<\/strong>. \u00d6ncesinde Cambrian Biopharma\u2019n\u0131n CIO\u2019su ve kurucu orta\u011f\u0131<\/strong>, Samsara Therapeutics\u2019in kurucu orta\u011f\u0131 ve COO\u2019su<\/strong>, Cyclone Therapeutics\u2019in kurucu orta\u011f\u0131 ve CEO\u2019su<\/strong> olarak \u00e7al\u0131\u015fm\u0131\u015ft\u0131r.<\/li>\n
      • Matthew \u2018Oki\u2019 O\u2019Connor<\/strong> \u2013 Senior Reviewer<\/strong>
        Richmond, California\u2019da bulunan O\u2019Connor, Baylor College of Medicine\u2019da biyokimya e\u011fitimi alm\u0131\u015ft\u0131r<\/strong>.<\/li>\n<\/ul>\n

        Bu ekip, VitaDAO<\/strong>\u2019nun b\u00fcy\u00fcmesine ve uzun \u00f6m\u00fcr ara\u015ft\u0131rmalar\u0131na y\u00f6nelik inovatif \u00e7\u00f6z\u00fcmler \u00fcretmesine liderlik etmektedir.<\/p>\n

        \"\"<\/p>\n

        Finansman ve Yat\u0131r\u0131mc\u0131lar<\/h2>\n

        VitaDAO<\/strong>, bug\u00fcne kadar toplam $11.2M<\/strong> finansman sa\u011flam\u0131\u015ft\u0131r. Yat\u0131r\u0131mc\u0131lar\u0131 aras\u0131nda Tioga Capital Partners, L1D, Balaji Srinivasan, Shine Capital ve Pfizer Venture Investments<\/strong> bulunmaktad\u0131r.<\/p>\n

        Finansman turlar\u0131 incelendi\u011finde, Kas\u0131m 2023\u2019te $2M<\/strong>, Ocak 2023\u2019te $3.6M<\/strong>, A\u011fustos 2022\u2019de Pfizer liderli\u011finde $500K<\/strong> ve Haziran 2021\u2019de \u00f6n tohum yat\u0131r\u0131m olarak $5.1M<\/strong> fon topland\u0131\u011f\u0131 g\u00f6r\u00fclmektedir.<\/p>\n

        Bunun yan\u0131 s\u0131ra VitaDAO<\/strong>, ImmuneAGE Bio<\/strong> ve Gero<\/strong> gibi projelere yat\u0131r\u0131m yaparak DeSci<\/strong> ekosisteminde b\u00fcy\u00fcmeye devam etmektedir.<\/p>\n

        \"\"<\/p>\n

        VITA Tokenomik Yap\u0131s\u0131<\/h2>\n

        VITA<\/strong> tokeninin toplam arz\u0131 64,298,880<\/strong> olarak belirlenmi\u015ftir. Tokenlerin %57.7\u2019si hazineye<\/strong> ayr\u0131l\u0131rken, geri kalan %42.3\u2019l\u00fck<\/strong> k\u0131s\u0131m farkl\u0131 gruplara tahsis edilmi\u015ftir. Bu da\u011f\u0131l\u0131m \u015fu \u015fekildedir: %10 Gnosis Token M\u00fczayedesi<\/strong>, %12.5 DAO \u00e7al\u0131\u015fma gruplar\u0131<\/strong>, %10 hizmet sa\u011flay\u0131c\u0131lar<\/strong> ve %9.8 stratejik yat\u0131r\u0131mc\u0131lar<\/strong>.<\/p>\n

        \"\"<\/p>\n

        Bilimsel ara\u015ft\u0131rmalar\u0131 fonlamak ve y\u00f6netmek art\u0131k VitaDAO<\/strong> ile merkeziyetsiz hale geliyor. Blockchain<\/strong> teknolojisi sayesinde, bilim insanlar\u0131 ve destek\u00e7ileri IP-NFT<\/strong> ve IPT<\/strong> sistemleriyle yenilik\u00e7i projelere yat\u0131r\u0131m yapabiliyor. Whitepaper<\/strong>\u2019a g\u00f6z atmak, toplulu\u011fa kat\u0131lmak veya daha fazla bilgi almak i\u00e7in a\u015fa\u011f\u0131daki ba\u011flant\u0131lar\u0131 ziyaret edebilirsiniz.<\/p>\n

        Whitepaper<\/strong>: VitaDAO Whitepaper<\/a>
        X (Twitter)<\/strong>:         VitaDAO X<\/a>
        Telegram<\/strong>:         VitaDAO Telegram<\/a><\/p>\n